Latest news
DNLI Q2 Loss Narrows, Avlayah Sales Drive Strong Launch Momentum - TradingViewTradingView · Fri, 07 Aug 2026 18:31:00 GMTDenali Therapeutics: Blood-Brain Barrier Platform Shows More Than 1,000x Greater Brain Exposure In Primates As AVLAYAH Launch Accelerates - Pulse 2.0Pulse 2.0 · Fri, 07 Aug 2026 15:50:29 GMTDenali Q2 2026 Earnings: AVLAYAH Launch Generates $3.6 Million - TradingKeyTradingKey · Fri, 07 Aug 2026 01:45:02 GMTDenali Therapeutics Inc. 2026: Revenue $3.6M, EPS ($0.68) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:11:01 GMTDenali Therapeutics (NASDAQ: DNLI) posts Q2 loss and launches AVLAYAH - Stock TitanStock Titan · Thu, 06 Aug 2026 20:09:23 GMT